Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Characterizing a Parkinson's Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa

              Author:Odin, Per   Pahwa, Rajesh   Farmer, Jill   Kimber, Thomas   Bergmans, Bruno   Freire Alvarez, Eric   Ray Chaudhuri, K   Gupta, Resmi   Yan, Connie H.   Bergmann, Lars   Kukreja, Pavnit   Antonini, Angelo   

              Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

              Topic:Movement Disorders  

              Program Number:P2.006  

              Author Institution:Lund University, Lund, Sweden, Bermerhaven, Germany  University of Kansas Medical Center, Kansas City, KS, USA, Kansas City, KS  Global Neurosciences Institute, Pennington, NJ, USA, Pennington, NJ  Royal Adelaide Hospital, Adelaide, Australia, Beulah Park, Australia  AZ St-Jan Brugge-Oostende AV, Bruges, Belgium and Ghent University Hospital, Ghent, Belgium, Bruges, Belgium  University General Hospital of Elche, Elche, Spain, Elche, Spain  King's College Hospital, London, UK, London, United Kingdom  AbbVie Inc., North Chicago, IL, USA, North Chicago, IL  AbbVie Inc., North Chicago, IL, USA, Ludwigshafen, Germany  University of Padua, Padua, Italy, Padova, Italy